380 related articles for article (PubMed ID: 17023675)
1. Cellular mechanism through which parathyroid hormone-related protein induces proliferation in arterial smooth muscle cells: definition of an arterial smooth muscle PTHrP/p27kip1 pathway.
Fiaschi-Taesch N; Sicari BM; Ubriani K; Bigatel T; Takane KK; Cozar-Castellano I; Bisello A; Law B; Stewart AF
Circ Res; 2006 Oct; 99(9):933-42. PubMed ID: 17023675
[TBL] [Abstract][Full Text] [Related]
2. Parathyroid-hormone-related protein as a regulator of pRb and the cell cycle in arterial smooth muscle.
Fiaschi-Taesch N; Takane KK; Masters S; Lopez-Talavera JC; Stewart AF
Circulation; 2004 Jul; 110(2):177-85. PubMed ID: 15210588
[TBL] [Abstract][Full Text] [Related]
3. Mutant parathyroid hormone-related protein, devoid of the nuclear localization signal, markedly inhibits arterial smooth muscle cell cycle and neointima formation by coordinate up-regulation of p15Ink4b and p27kip1.
Fiaschi-Taesch N; Sicari B; Ubriani K; Cozar-Castellano I; Takane KK; Stewart AF
Endocrinology; 2009 Mar; 150(3):1429-39. PubMed ID: 18845646
[TBL] [Abstract][Full Text] [Related]
4. c-myc and skp2 coordinate p27 degradation, vascular smooth muscle proliferation, and neointima formation induced by the parathyroid hormone-related protein.
Sicari BM; Troxell R; Salim F; Tanwir M; Takane KK; Fiaschi-Taesch N
Endocrinology; 2012 Feb; 153(2):861-72. PubMed ID: 22210745
[TBL] [Abstract][Full Text] [Related]
5. Coordinate control of proliferation and migration by the p27Kip1/cyclin-dependent kinase/retinoblastoma pathway in vascular smooth muscle cells and fibroblasts.
Díez-Juan A; Andrés V
Circ Res; 2003 Mar; 92(4):402-10. PubMed ID: 12600894
[TBL] [Abstract][Full Text] [Related]
6. A novel mechanism of transcriptional repression of p27kip1 through Notch/HRT2 signaling in vascular smooth muscle cells.
Havrda MC; Johnson MJ; O'Neill CF; Liaw L
Thromb Haemost; 2006 Sep; 96(3):361-70. PubMed ID: 16953280
[TBL] [Abstract][Full Text] [Related]
7. Downregulation of cyclin-dependent kinase inhibitor; p57(kip2), is involved in the cell cycle progression of vascular smooth muscle cells.
Nakano N; Urasawa K; Takagi Y; Saito T; Kaneta S; Ishikawa S; Higashi H; Tsutsui H; Hatakeyama M; Kitabatake A
Biochem Biophys Res Commun; 2005 Dec; 338(3):1661-7. PubMed ID: 16259944
[TBL] [Abstract][Full Text] [Related]
8. Local cyclin-dependent kinase inhibition by flavopiridol inhibits coronary artery smooth muscle cell proliferation and migration: Implications for the applicability on drug-eluting stents to prevent neointima formation following vascular injury.
Jaschke B; Milz S; Vogeser M; Michaelis C; Vorpahl M; Schömig A; Kastrati A; Wessely R
FASEB J; 2004 Aug; 18(11):1285-7. PubMed ID: 15180955
[TBL] [Abstract][Full Text] [Related]
9. Mevastatin can cause G1 arrest and induce apoptosis in pulmonary artery smooth muscle cells through a p27Kip1-independent pathway.
Fouty BW; Rodman DM
Circ Res; 2003 Mar; 92(5):501-9. PubMed ID: 12600884
[TBL] [Abstract][Full Text] [Related]
10. Enhanced proteasome-dependent degradation of the CDK inhibitor p27(kip1) in immortalized lymphocytes from Alzheimer's dementia patients.
Muñoz U; Bartolomé F; Bermejo F; Martín-Requero A
Neurobiol Aging; 2008 Oct; 29(10):1474-84. PubMed ID: 17448572
[TBL] [Abstract][Full Text] [Related]
11. Parathyroid hormone-related protein induces hypertrophy in podocytes via TGF-beta(1) and p27(Kip1): implications for diabetic nephropathy.
Romero M; Ortega A; Izquierdo A; López-Luna P; Bosch RJ
Nephrol Dial Transplant; 2010 Aug; 25(8):2447-57. PubMed ID: 20200004
[TBL] [Abstract][Full Text] [Related]
12. Cyclin dependent kinase inhibitor p27(Kip1) is upregulated by hypoxia via an ARNT dependent pathway.
Wang G; Reisdorph R; Clark RE; Miskimins R; Lindahl R; Miskimins WK
J Cell Biochem; 2003 Oct; 90(3):548-60. PubMed ID: 14523989
[TBL] [Abstract][Full Text] [Related]
13. Evidence for cytosolic p27(Kip1) ubiquitylation and degradation during adipocyte hyperplasia.
Auld CA; Morrison RF
Obesity (Silver Spring); 2006 Dec; 14(12):2136-44. PubMed ID: 17189539
[TBL] [Abstract][Full Text] [Related]
14. 3-Deazaadenosine prevents smooth muscle cell proliferation and neointima formation by interfering with Ras signaling.
Sedding DG; Tröbs M; Reich F; Walker G; Fink L; Haberbosch W; Rau W; Tillmanns H; Preissner KT; Bohle RM; Langheinrich AC
Circ Res; 2009 May; 104(10):1192-200. PubMed ID: 19372464
[TBL] [Abstract][Full Text] [Related]
15. Density-dependent shift of transforming growth factor-beta-1 from inhibition to stimulation of vascular smooth muscle cell growth is based on unconventional regulation of proliferation, apoptosis and contact inhibition.
Hneino M; Bouazza L; Bricca G; Li JY; Langlois D
J Vasc Res; 2009; 46(2):85-97. PubMed ID: 18596377
[TBL] [Abstract][Full Text] [Related]
16. Oxidized LDL induces proliferation and hypertrophy in human umbilical vein endothelial cells via regulation of p27Kip1 expression: role of RhoA.
Seibold S; Schürle D; Heinloth A; Wolf G; Wagner M; Galle J
J Am Soc Nephrol; 2004 Dec; 15(12):3026-34. PubMed ID: 15579505
[TBL] [Abstract][Full Text] [Related]
17. Fluvastatin synergistically improves the antiproliferative effect of everolimus on rat smooth muscle cells by altering p27Kip1/cyclin E expression.
Ferri N; Granata A; Pirola C; Torti F; Pfister PJ; Dorent R; Corsini A
Mol Pharmacol; 2008 Jul; 74(1):144-53. PubMed ID: 18413661
[TBL] [Abstract][Full Text] [Related]
18. Skp2-mediated p27(Kip1) degradation during S/G2 phase progression of adipocyte hyperplasia.
Auld CA; Fernandes KM; Morrison RF
J Cell Physiol; 2007 Apr; 211(1):101-11. PubMed ID: 17096381
[TBL] [Abstract][Full Text] [Related]
19. STAT1 requirement for PKR-induced cell cycle arrest in vascular smooth muscle cells in response to heparin.
Handy I; Patel RC
Gene; 2013 Jul; 524(1):15-21. PubMed ID: 23597922
[TBL] [Abstract][Full Text] [Related]
20. YSK2821, a newly synthesized indoledione derivative, inhibits cell proliferation and cell cycle progression via the cell cycle-related proteins by regulating phosphatidylinositol-3 kinase cascade in vascular smooth muscle cells.
Seo JM; Kim TJ; Jin YR; Han HJ; Ryu CK; Sheen YY; Kim DW; Yun YP
Eur J Pharmacol; 2008 May; 586(1-3):74-81. PubMed ID: 18402936
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]